天天向上-身高管理 is a pediatric growth-tracking utility for parents, providing clinical-grade height assessment and genetic target height calculations on iOS.
The App DNA
What makes this app unique?
Users hire the app to monitor child development against authoritative clinical datasets, fulfilling a need for precise health documentation that generic baby trackers often lack.
For Parents and guardians monitoring child development who require clinical reference data for growth assessment.
Key features
Plots child height data against WHO, Chinese Health Commission, and Hong Kong 2020 reference datasets.
Computes potential adult height using CMH, FPH, CMH-C, and FPH-C clinical formulas.
Supports separate health profiles and growth records for multiple children within one account.
How much does it cost?
The app currently operates as a free utility with no visible subscription or IAP gates.
Velocity
Dormant developmentopaqueShow more...
The app has not received any updates since November 19, 2025, resulting in a total lack of development activity over the last 7.5 months. Given the absence of releases within the last three months, the development status is classified as a zombie. There is no evidence of ongoing maintenance, feature development, or live operations.
Who built it?
婷婷 乔
13+ apps tracked · Lifestyle
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for 天天向上-身高管理
How's the Lifestyle market?
天天向上-身高管理 occupies a specialized niche in the Lifestyle category, focusing on clinical data precision rather than the broad activity-logging features of market leaders. Its current free-only model lacks the monetization friction of rivals, but the absence of multi-user sync limits its competitive reach against established trackers.
Read the market outlookThe rivals identified
By BALTAPIS UAB
This app directly competes by offering comprehensive growth tracking and health logging, serving as a primary alternative for parents monitoring child development.
- Offers advanced sleep prediction algorithms that provide actionable insights beyond simple manual growth logging.
- Features real-time family synchronization, allowing multiple caregivers to update and view data simultaneously.
- Maintains a massive user base and high review volume, creating a strong network effect.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for 天天向上-身高管理
Where is it heading?
Casual baby-tracking traffic is consolidating around apps that offer real-time family synchronization, leaving manual-entry tools like 天天向上-身高管理 exposed to churn. The app's clinical depth is a strong niche, but the lack of collaborative features creates a ceiling on its growth potential as parents prioritize convenience over raw data entry.
- Lack of multi-user sync forces parents to choose more collaborative rivals, accelerating churn pressure into the next quarter.
- The clinical-formula focus (CMH, FPH) remains a strong differentiator for the target audience, maintaining a stable, albeit small, user base.
The SWOT
- Clinical-grade growth assessment using multiple international reference datasets
- Specialized genetic target height calculation formulas (CMH, FPH)
- Multi-child profile management for organized family health records
- Integrate cloud-based family sharing to enable collaborative tracking
- Add automated vaccination or symptom logging to increase daily active usage
Next best moves
Ship cloud-based family synchronization because it is the primary feature gap versus the nemesis → increase daily active usage and retention.
+ 1 more prioritized moveThe counter-intuitive read
The app's clinical depth is a moat for power users…
Read the full takeFeature gaps
Real-time family synchronization (available in Baby Daybook but absent here) +1
Since the last report: The app's competitive outlook has shifted toward addressing its lack of multi-user synchronization, with the PM prioritizing cloud-sync to counter churn to collaborative rivals.
Bottom line
天天向上-身高管理 succeeds as a clinical reference tool because it provides specific, authoritative growth calculations, so the PM should prioritize cloud-based family synchronization to prevent churn to more collaborative, multi-user alternatives.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated